Catalyst Biosciences Inc

NASDAQ:CBIO   3:59:50 PM EDT
3.28
-0.14 (-4.09%)
Products

FDA Grants Catalyst Biosciences Orphan Drug Designation For Marzaa For The Treatment Of Factor VII Deficiency

Published: 09/28/2021 20:21 GMT
Catalyst Biosciences Inc (CBIO) - FDA Grants Catalyst Biosciences Orphan Drug Designation for Marzaa for the Treatment of Factor Vii Deficiency.